Additional European Equity News

AstraZeneca (AZN LN) - Enhertu plus Perjeta granted priority review in the US as first-line treatment for patients with HER2-positive metastatic breast cancer. (Newswires)

Atos (ATO FP) - Secured a European Commission cybersecurity contract, for a maximum of EUR 326mln. (Newswires)

Iberdrola (IBE SM) - Co. to invest EUR 59bln in 2028, sees adj. Net profit of EUR 7.6bln by 2028. Sees close to EUR 20bln in dividends between 2025 and 2028. Additional growth expected in FY26. (Newswires)

JD Sports (JD/ LN) - H1 (GBP); Revenue 5.94bln (exp. 5.94bln), adj. pre-tax profit 0.351bln (exp. 0.364bln), FY profit pre-tax in line with expectations, expects limited impact from US tariffs, remains cautious on trading environment for H2. CFO: We think Nike (NKE) is doing the right things to reshape the business. (Newswires)

Mercedes Benz (MBG GY) - CTO to leave Co. once his contract expires. (Newswires) 

Novartis (NOVN SW) - New data further supports the benefits of Kesimpta in relapsing MS. (Newswires)

Roche AG (ROG SZ) - Presented new data for Ocrevus and Fenebrutinib, Ocrevus shows reduces disability progression risk by 30% in PPMS, Fenebrutinib showed near-complete suppression of disease activity at 96 weeks. (Newswires)  

Saga plc (SAGA LN) - H1 (GBP): Revenue 328.2mln (prev. 300.6mln Y/Y), PBT 23.5mln (prev. 24.8mln Y/Y). H1 results ahead of expectations driven by strength in travel, H2 forward bookings are strong, the delivery of strategic plans are on track. (Newswires)

Associated British Foods (ABF LN) upgraded to Hold from Sell at Deutsche Bank

Bouygues (EN FP) upgraded to equal-weight from underweight at Morgan Stanley.

Evonik (EVK GY) downgraded to Hold from Buy at Deutsche Bank

Lanxess (LXS GY) downgraded to Hold from Buy at Deutsche Bank 

Porsche (P911 GY) downgraded to Sell from Hold at Bankhaus Mezler